en

PRODUCT DETAIL

Rapiscan 400 mikrogramov injekčný roztok

Code 23286
MA number EU/1/10/643/001
Product Form: sol inj 1x5 ml/400 µg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 41 - CARDIACA
ATC:
C CARDIOVASCULAR SYSTEM
C01 CARDIAC THERAPY
C01E OTHER CARDIAC PREPARATIONS
C01EB Other cardiac preparations
C01EB21 Regadenoson
Shelf life: 48
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 06.09.2010
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 26.01.2022
eu-flag.png sk-flag.png